Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary Tract.
Rammal R, Koll FJ, Chen Z, Tallman JE, Alam SM, Eichholz J, Chatila W, Agbamu T, Lenis AT, Basar M, Yol C, Chen JF, Sarungbam J, Chen Y, Gopalan A, Fine SW, Tickoo SK, Antonescu CR, Weigelt B, Abu-Rustum NR, Grisham RN, Momeni-Boroujeni A, Pietzak EJ, Bochner BH, Rosenberg JE, Iyer G, Reuter VE, Solit DB, Al-Ahmadie H. Rammal R, et al. Among authors: grisham rn. Mod Pathol. 2025 Jun 17:100821. doi: 10.1016/j.modpat.2025.100821. Online ahead of print. Mod Pathol. 2025. PMID: 40553939
Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics.
Ring KL, Mills AM, Howitt BE, Grisham RN, Euscher ED, Kim HS, Klopp AH, Kolin DL, McCluggage WG, Mirkovic J, Park KJ, Aoun E, Awujo C, Son J, Mok SC, Ferri-Borgogno S, Hong DS, Hoang L, Jazaeri AA, How JA, Lu KH. Ring KL, et al. Among authors: grisham rn. Gynecol Oncol. 2025 Jun;197:57-65. doi: 10.1016/j.ygyno.2025.04.583. Epub 2025 Apr 24. Gynecol Oncol. 2025. PMID: 40279981 Review.
Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugate.
Johannet P, Flint M, Chui MH, Konner J, Friedman C, Green AK, Guo R, Hensley ML, Kyi C, Liu Y, Makker V, Rubinstein M, Sabbatini P, Tew WP, Foote MB, Weigelt B, Aghajanian C, Grisham RN, O'Cearbhaill RE. Johannet P, et al. Among authors: grisham rn. Gynecol Oncol. 2025 Apr;195:173-179. doi: 10.1016/j.ygyno.2025.03.023. Epub 2025 Mar 22. Gynecol Oncol. 2025. PMID: 40121972
Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovary.
Finch L, Andres S, Iasonos A, Zhou Q, Girshman J, Chhetri-Long R, Green H, Selenica P, Jang D, O'Cearbhaill RE, Kyi C, Cohen S, Friedman CF, Makker V, Chi DS, Sonoda Y, Chiang S, Aghajanian C, Weigelt B, Grisham RN. Finch L, et al. Among authors: grisham rn. Int J Gynecol Cancer. 2025 Jan;35(1):100005. doi: 10.1016/j.ijgc.2024.100005. Epub 2024 Dec 18. Int J Gynecol Cancer. 2025. PMID: 39878266 Clinical Trial.
Association between genomic instability score and progression-free/overall survival in patients with newly diagnosed non-BRCA1/2 ovarian cancer.
Graves S, Sullivan MW, Adkoli A, Zhou Q, Iasonos A, Selenica P, Aghajanian C, Liu YL, Tew W, Sonoda Y, Ellenson LH, Chi D, O'Cearbhaill RE, Weigelt B, Grisham RN. Graves S, et al. Among authors: grisham rn. Gynecol Oncol. 2025 Jan;192:120-127. doi: 10.1016/j.ygyno.2024.11.011. Epub 2024 Dec 7. Gynecol Oncol. 2025. PMID: 39647188
87 results